These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23208884)

  • 1. Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.
    Trindade MÂ; Miyamoto D; Benard G; Sakai-Valente NY; Vasconcelos Dde M; Naafs B
    Am J Trop Med Hyg; 2013 Feb; 88(2):236-40. PubMed ID: 23208884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients.
    Cardoso FL; Antas PR; Milagres AS; Geluk A; Franken KL; Oliveira EB; Teixeira HC; Nogueira SA; Sarno EN; Klatser P; Ottenhoff TH; Sampaio EP
    Infect Immun; 2002 Dec; 70(12):6707-14. PubMed ID: 12438345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
    García-Rodríguez JF; Valcarce-Pardeiro N; Álvarez-Díaz H; Mariño-Callejo A
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2121-2126. PubMed ID: 31377953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-existence of mycobacterial infections: is it an emerging issue with retroviral infections?
    Keragala B; Herath H; Janappriya G; Gunasekera CN
    Trop Doct; 2019 Apr; 49(2):145-146. PubMed ID: 30582730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responses.
    Díaz A; Bongiovanni B; D'Attilio L; Santucci N; Dídoli G; Fernández RDV; Kovalevski L; Lioi S; Gardeñez W; Brandan N; Nannini LJ; Besedovsky H; Del Rey A; Bottasso O; Bay ML
    Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28854691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
    Schechter M; Zajdenverg R; Falco G; Barnes GL; Faulhaber JC; Coberly JS; Moore RD; Chaisson RE
    Am J Respir Crit Care Med; 2006 Apr; 173(8):922-6. PubMed ID: 16474028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.
    Thee S; Seddon JA; Donald PR; Seifart HI; Werely CJ; Hesseling AC; Rosenkranz B; Roll S; Magdorf K; Schaaf HS
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5560-7. PubMed ID: 21968358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China.
    Li S; Lin L; Zhang F; Zhao C; Meng H; Wang H
    BMC Infect Dis; 2020 May; 20(1):362. PubMed ID: 32448123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia.
    Wondale B; Medihn G; Teklu T; Mersha W; Tamirat M; Ameni G
    BMC Res Notes; 2017 Dec; 10(1):680. PubMed ID: 29202880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis and Leprosy Coinfection: A Perspective on Diagnosis and Treatment.
    Mangum L; Kilpatrick D; Stryjewska B; Sampath R
    Open Forum Infect Dis; 2018 Jul; 5(7):ofy133. PubMed ID: 30046638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinfection of leprosy and tuberculosis.
    Shetty S; Umakanth S; Manandhar B; Nepali PB
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
    Ishiwada N; Tokunaga O; Nagasawa K; Ichimoto K; Kinoshita K; Hishiki H; Kohno Y
    Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the performances of MTD Gene-Probe® test, BACTEC 960™ system and Löwenstein-Jensen culture methods in the diagnosis of smear-negative tuberculosis cases].
    Kunduracıoğlu A; Karasu I; Biçmen C; Ozsöz A; Erbaycu AE
    Mikrobiyol Bul; 2013 Jul; 47(3):417-31. PubMed ID: 23971920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.
    Huang Z; Gao C; Chi X; Hu YW; Zheng L; Zeng T; Wang Q
    Scand J Immunol; 2015 Oct; 82(4):370-9. PubMed ID: 26073153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
    Bekker A; Schaaf HS; Draper HR; van der Laan L; Murray S; Wiesner L; Donald PR; McIlleron HM; Hesseling AC
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2171-9. PubMed ID: 26810651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.